Evolving Adjuvant Therapy in Early-Stage EGFR-Mutated NSCLC: Insights From ADAURA - CancerNetwork

Evolving Adjuvant Therapy in Early-Stage EGFR-Mutated NSCLC: Insights From ADAURA  CancerNetwork

Peliosis Hepatis Presenting As Pseudometastatic Liver Lesions During Adjuvant Therapy for Colon C...

Peliosis Hepatis Presenting As Pseudometastatic Liver Lesions During Adjuvant Therapy for Colon Cancer: A Case Report  Cureus

Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence - The...

Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence  The ASCO Post

Managing Progression After Adjuvant Therapy in Advanced RCC - OncLive

Managing Progression After Adjuvant Therapy in Advanced RCC  OncLive

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC  Nature

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - The New England Journal of...

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer  The New England Journal of Medicine

Adjuvant Selpercatinib Improves EFS in RET Fusion–Positive NSCLC - Targeted Oncology

Adjuvant Selpercatinib Improves EFS in RET Fusion–Positive NSCLC  Targeted Oncology

ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter ...

ASTRO 2025: Bladder Adjuvant Radiotherapy (BART): Clinical Outcomes from a Phase III Multicenter Randomized Controlled Trial  UroToday

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralis...

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service  Nature

Adjuvant Durvalumab in Resected Early-Stage NSCLC - The ASCO Post

Adjuvant Durvalumab in Resected Early-Stage NSCLC  The ASCO Post

Adjuvant Nivolumab Plus Chemo Decreases Disease Relapse Rates vs Chemo in Resected NSCLC - OncLive

Adjuvant Nivolumab Plus Chemo Decreases Disease Relapse Rates vs Chemo in Resected NSCLC  OncLive

Aromatase Inhibitors Favored as Adjuvant ET in HR+/HER2+ Early Breast Cancer - Targeted Oncology

Aromatase Inhibitors Favored as Adjuvant ET in HR+/HER2+ Early Breast Cancer  Targeted Oncology

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASC...

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer  The ASCO Post

Discovery of a small molecule TLR3 agonist adjuvant - Nature

Discovery of a small molecule TLR3 agonist adjuvant  Nature

Adjuvant Aumolertinib in EGFR-Mutated NSCLC - The ASCO Post

Adjuvant Aumolertinib in EGFR-Mutated NSCLC  The ASCO Post

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics - Nature

A host-directed adjuvant sensitizes intracellular bacterial persisters to antibiotics  Nature

PD-1 Inhibitor Approved for Adjuvant Treatment of CSCC - The ASCO Post

PD-1 Inhibitor Approved for Adjuvant Treatment of CSCC  The ASCO Post

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized ph...

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial  Nature

Adjuvant Pembrolizumab in Merkel Cell Carcinoma - The ASCO Post

Adjuvant Pembrolizumab in Merkel Cell Carcinoma  The ASCO Post

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer...

Adjuvant Radiation Therapy Safe and Beneficial in Locally Advanced Muscle-Invasive Bladder Cancer  The ASCO Post

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery - PNAS

Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery  PNAS

The efficacy of adjuvant chemotherapy after total mesorectal excision without selective lateral l...

The efficacy of adjuvant chemotherapy after total mesorectal excision without selective lateral lymph node dissection for locally advanced rectal cancer  Nature

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC - The ASCO Post

Adjuvant Chemoimmunotherapy for Resected Stage IB–IIIA NSCLC  The ASCO Post

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098...

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial  Nature

World-first library of vaccine-enhancing adjuvants launches - CEPI

World-first library of vaccine-enhancing adjuvants launches  CEPI

Chronic Toxicity Rates With De-escalated vs Standard Adjuvant Radiotherapy in HPV-Associated Orop...

Chronic Toxicity Rates With De-escalated vs Standard Adjuvant Radiotherapy in HPV-Associated Oropharyngeal Squamous Cell Carcinoma  The ASCO Post

Adjuvant S-1 plus endocrine therapy for ER-positive, HER2-negative, primary breast cancer: post-P...

Adjuvant S-1 plus endocrine therapy for ER-positive, HER2-negative, primary breast cancer: post-POTENT trial prognostic survey | npj Breast Cancer  Nature

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy - T...

Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy  The ASCO Post

Impact of neoadjuvant and adjuvant chemotherapy on breast cancer prognosis in a propensity score ...

Impact of neoadjuvant and adjuvant chemotherapy on breast cancer prognosis in a propensity score matched population  Nature

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through...

Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization  Nature

Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screeni...

Adjuvant activity of a small molecule TLR4 agonist discovered via structure-based virtual screening  Nature

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy:...

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial  American Heart Association Journals

Adjuvant Alectinib Impresses in Updated ALINA Results for ALK+ NSCLC - OncLive

Adjuvant Alectinib Impresses in Updated ALINA Results for ALK+ NSCLC  OncLive

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization...

Rational adjuvant selection for the neonatal period shapes unique and lasting immune polarization in mice  Nature

Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom? - The Lancet

Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom?  The Lancet

Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC? ...

Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC?  ASCO Daily News

10-Year Outcomes With Adjuvant Metronomic Capecitabine in Early Triple-Negative Breast Cancer - T...

10-Year Outcomes With Adjuvant Metronomic Capecitabine in Early Triple-Negative Breast Cancer  The ASCO Post

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer - The New England Journal of Med...

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer  The New England Journal of Medicine

An NLRP3-stimulatory adjuvant improves the immunogenicity of influenza virus vaccines in mice and...

An NLRP3-stimulatory adjuvant improves the immunogenicity of influenza virus vaccines in mice and non-human primates  ASM Journals

Giredestrant Becomes First Oral SERD to Show iDFS Benefit As Adjuvant Therapy in Early ER+, HER2-...

Giredestrant Becomes First Oral SERD to Show iDFS Benefit As Adjuvant Therapy in Early ER+, HER2-Negative Breast Cancer  OncLive

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and...

Age Threshold for Survival Benefit of Adding Oxaliplatin to Adjuvant Chemotherapy in Stage II and III Colorectal Cancer  The ASCO Post

Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cer...

Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cervical intraepithelial neoplasia lesions in women undergoing lesion surgical treatment (VACCIN): a multicentre, phase 4 randomised placebo-controlled trial in th  The Lancet

Tailoring Adjuvant Therapy for Younger Patients with Low-Risk Breast Cancer - Memorial Sloan Kett...

Tailoring Adjuvant Therapy for Younger Patients with Low-Risk Breast Cancer  Memorial Sloan Kettering Cancer Center

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma - The New England J...

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma  The New England Journal of Medicine

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protect...

Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protection against heterologous pandemic and endemic viruses | Cellular & Molecular Immunology  Nature

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer - The A...

Use of Adjuvant Aspirin Reduces the Risk of Recurrence in PI3K -Mutated Colorectal Cancer  The ASCO Post

Adjuvant ALK TKIs show robust and durable disease-free survival benefit in non-small cell lung ca...

Adjuvant ALK TKIs show robust and durable disease-free survival benefit in non-small cell lung cancer  ESMO Daily Reporter

Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Out...

Adjuvant Chemoradiotherapy vs Radiotherapy for High-Risk Endometrial Cancer: 10-Year PORTEC-3 Outcomes  The ASCO Post

Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy - AJMC

Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy  AJMC

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds - Georgia S...

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds  Georgia State University News

Harmonizing yin and yang, remodeling the microenvironment: the adjuvant potential of Chinese herb...

Harmonizing yin and yang, remodeling the microenvironment: the adjuvant potential of Chinese herbal medicine in tumor immunotherapy  Frontiers

Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the...

Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial  Nature

Extended Follow-up for Neoadjuvant and Adjuvant Relatlimab Plus Nivolumab in Resectable Melanoma ...

Extended Follow-up for Neoadjuvant and Adjuvant Relatlimab Plus Nivolumab in Resectable Melanoma  The ASCO Post

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer - On...

Adjuvant Abemaciclib Plus Endocrine Therapy Improves OS in High-Risk HR+/HER2– Breast Cancer  OncLive

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy...

Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy  The ASCO Post

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Co...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer  The ASCO Post

Adjuvant Camrelizumab Plus Capecitabine in Intrahepatic Cholangiocarcinoma After Surgical Resecti...

Adjuvant Camrelizumab Plus Capecitabine in Intrahepatic Cholangiocarcinoma After Surgical Resection: Chinese Phase 2 Trial  Oncodaily

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as mol...

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial  The Lancet

ctDNA-guided adjuvant chemotherapy in colon cancer: not ready for prime time? - ESMO Daily Reporter

ctDNA-guided adjuvant chemotherapy in colon cancer: not ready for prime time?  ESMO Daily Reporter

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma - The ASCO Post

Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma  The ASCO Post

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer as...

Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer assessed through SEER database analysis  Nature

Adjuvant Therapy in Cancer: Benefits, Types, Timing, and Precision-Based Innovations - Oncodaily

Adjuvant Therapy in Cancer: Benefits, Types, Timing, and Precision-Based Innovations  Oncodaily

Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopha...

Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma  Nature

Adjuvant Encorafenib/Binimetinib Is Well Tolerated and May Reduce Recurrence Risk in BRAF V600–Mu...

Adjuvant Encorafenib/Binimetinib Is Well Tolerated and May Reduce Recurrence Risk in BRAF V600–Mutant Melanoma  OncLive

Abemaciclib or Ribociclib: Choosing a CDK4/6 Inhibitor in ER-Positive/HER2-Negative Stage III Ear...

Abemaciclib or Ribociclib: Choosing a CDK4/6 Inhibitor in ER-Positive/HER2-Negative Stage III Early Breast Cancer in the Adjuvant Setting  ASCO Daily News

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma - Cleveland Clinic

Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma  Cleveland Clinic

Frank A. Sinicrope, MD, on Adjuvant Treatment Strategies for Stage III dMMR Colon Cancer - The AS...

Frank A. Sinicrope, MD, on Adjuvant Treatment Strategies for Stage III dMMR Colon Cancer  The ASCO Post

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squam...

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squamous Cell Carcinoma  ASCO Daily News

Need an adjuvant? Check the library - National Research Council Canada

Need an adjuvant? Check the library  National Research Council Canada

Mortality Associated With Risk-Adapted Adjuvant Therapy in Postmenopausal Women With Early Breast...

Mortality Associated With Risk-Adapted Adjuvant Therapy in Postmenopausal Women With Early Breast Cancer  The ASCO Post

Shingles and RSV vaccines with AS01 adjuvant reduce dementia risk - News-Medical

Shingles and RSV vaccines with AS01 adjuvant reduce dementia risk  News-Medical

What is the role of adjuvant immunotherapy in contemporary melanoma care? - ESMO Daily Reporter

What is the role of adjuvant immunotherapy in contemporary melanoma care?  ESMO Daily Reporter

Early Adjuvant Immunotherapy Discontinuation Does Not Affect Melanoma Recurrence Risk - AJMC

Early Adjuvant Immunotherapy Discontinuation Does Not Affect Melanoma Recurrence Risk  AJMC

Adding adjuvant pertuzumab demonstrates prolonged survival benefit after 10+ years in HER2+ breas...

Adding adjuvant pertuzumab demonstrates prolonged survival benefit after 10+ years in HER2+ breast cancer  ESMO Daily Reporter

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival a...

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis  Nature

New Paper Alert: Adjuvant CDK4/6 Inhibitors: Promising or Problematic? A Critical Review of the E...

New Paper Alert: Adjuvant CDK4/6 Inhibitors: Promising or Problematic? A Critical Review of the Evidence  Oncodaily

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic adm...

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic administration  Nature

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma - The New Engla...

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

The scientific journey of a novel adjuvant (AS37) from bench to bedside - Nature

The scientific journey of a novel adjuvant (AS37) from bench to bedside  Nature

Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and surv...

Adjuvant chemotherapy in localized, resectable extremity and truncal soft tissue sarcoma and survival outcomes – A systematic review and meta-analysis of randomized controlled trials  Wiley

Adjuvant Keytruda Improves Kidney Cancer Survival - National Cancer Institute (.gov)

Adjuvant Keytruda Improves Kidney Cancer Survival  National Cancer Institute (.gov)

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–II...

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–IIIA non-small-cell lung cancer  Nature

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - The New England Journa...

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma  The New England Journal of Medicine

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - The New England Journal of Med...

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma  The New England Journal of Medicine

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine - National Inst...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine  National Institutes of Health (.gov)

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer - The New England Jou...

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer  The New England Journal of Medicine

Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma - ASCO Publications

Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma  ASCO Publications

Adjuvant Chemotherapy for Early-Onset Stage II Colon Cancer - ASCO Publications

Adjuvant Chemotherapy for Early-Onset Stage II Colon Cancer  ASCO Publications

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer - The New England J...

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer  The New England Journal of Medicine

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - The New Englan...

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer  The New England Journal of Medicine

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer - The New Englan...

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer  The New England Journal of Medicine

A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussis ...

A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussis | npj Vaccines  Nature

Adjuvant Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - The ASCO ...

Adjuvant Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer  The ASCO Post

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - The New England Jou...

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  The New England Journal of Medicine

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma - The New England Journ...

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma  The New England Journal of Medicine

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy - The New England Journal...

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy  The New England Journal of Medicine

Should Adjuvant Immunotherapy Be Given to Patients With Kidney or Bladder Cancer? - ASCO Daily News

Should Adjuvant Immunotherapy Be Given to Patients With Kidney or Bladder Cancer?  ASCO Daily News

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma - Nature

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma  Nature

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer - The New England Jo...

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer  The New England Journal of Medicine

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal canc...

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer  Nature